Komarova EA - Search Results

1

p53 is essential for chemotherapy-induced hair loss.

Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Komarov PG, Maurer M, Gilchrest BA, Gudkov AV. Botchkarev VA, et al. Among authors: komarova ea. Cancer Res. 2000 Sep 15;60(18):5002-6. Cancer Res. 2000. PMID: 11016618

2

p53 Involvement in the control of murine hair follicle regression.

Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Sharov AA, Komarov PG, Maurer M, Gudkov AV, Gilchrest BA. Botchkarev VA, et al. Among authors: komarova ea. Am J Pathol. 2001 Jun;158(6):1913-9. doi: 10.1016/S0002-9440(10)64659-7. Am J Pathol. 2001. PMID: 11395365 Free PMC article.

3

The role of p53 in determining sensitivity to radiotherapy.

Gudkov AV, Komarova EA. Gudkov AV, et al. Among authors: komarova ea. Nat Rev Cancer. 2003 Feb;3(2):117-29. doi: 10.1038/nrc992. Nat Rev Cancer. 2003. PMID: 12563311 Review.

4

Prospective therapeutic applications of p53 inhibitors.

Gudkov AV, Komarova EA. Gudkov AV, et al. Among authors: komarova ea. Biochem Biophys Res Commun. 2005 Jun 10;331(3):726-36. doi: 10.1016/j.bbrc.2005.03.153. Biochem Biophys Res Commun. 2005. PMID: 15865929 Review.

5

Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.

Burdelya LG, Komarova EA, Hill JE, Browder T, Tararova ND, Mavrakis L, DiCorleto PE, Folkman J, Gudkov AV. Burdelya LG, et al. Among authors: komarova ea. Cancer Res. 2006 Oct 1;66(19):9356-61. doi: 10.1158/0008-5472.CAN-06-1223. Cancer Res. 2006. PMID: 17018587

6

Pathologies associated with the p53 response.

Gudkov AV, Komarova EA. Gudkov AV, et al. Among authors: komarova ea. Cold Spring Harb Perspect Biol. 2010 Jul;2(7):a001180. doi: 10.1101/cshperspect.a001180. Epub 2010 Apr 7. Cold Spring Harb Perspect Biol. 2010. PMID: 20595398 Free PMC article. Review.

7

Could p53 be a target for therapeutic suppression?

Komarova EA, Gudkov AV. Komarova EA, et al. Semin Cancer Biol. 1998;8(5):389-400. doi: 10.1006/scbi.1998.0101. Semin Cancer Biol. 1998. PMID: 10101804 Review.

8

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. Komarov PG, et al. Among authors: komarova ea. Science. 1999 Sep 10;285(5434):1733-7. doi: 10.1126/science.285.5434.1733. Science. 1999. PMID: 10481009

9

Suppression of p53: a new approach to overcome side effects of antitumor therapy.

Komarova EA, Gudkov AV. Komarova EA, et al. Biochemistry (Mosc). 2000 Jan;65(1):41-8. Biochemistry (Mosc). 2000. PMID: 10702639 Free article. Review.

10

Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors.

Komarova EA, Gudkov AV. Komarova EA, et al. Biochem Pharmacol. 2001 Sep 15;62(6):657-67. doi: 10.1016/s0006-2952(01)00733-x. Biochem Pharmacol. 2001. PMID: 11556286 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters